Polypill: an affordable strategy for cardiovascular disease prevention in low-medium-income countries. [electronic resource]
- Therapeutic advances in cardiovascular disease Jun 2018
- 169-174 p. digital
Publication Type: Journal Article; Review
1753-9455
10.1177/1753944718764588 doi
Antihypertensive Agents--economics Cardiovascular Diseases--diagnosis Developing Countries--economics Drug Combinations Drug Costs Health Services Accessibility--economics Humans Hypolipidemic Agents--economics Income Medication Adherence Platelet Aggregation Inhibitors--economics Polypharmacy Primary Prevention--economics Risk Factors Secondary Prevention--economics Treatment Outcome